MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
897.59%
Quick Ratio
897.59%
Cash Ratio
308.16%
Debt to Asset Ratio
11.42%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Less accumulated depreciation
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, non...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
34,064 41,499 35,405 41,895
Short-term investments
63,673 77,083 93,849 95,528
Prepaid expenses and other current assets
1,483 1,863 1,107 989
Total current assets
99,220 120,445 130,361 138,412
Total property and equipment
8,354 8,207 8,146 NaN
Less accumulated depreciation
3,701 3,318 2,957 NaN
Property and equipment, net
4,653 4,889 5,189 5,072
Operating lease right-of-use assets
2,255 2,527 2,792 3,052
Long-term investments
NaN NaN 5,108 10,199
Restricted cash
194 203 202 201
Other assets
1,510 1,653 1,647 1,647
Total assets
107,832 129,717 145,299 158,583
Accounts payable
1,162 2,277 996 1,163
Accrued expenses and other current liabilities
8,740 12,215 12,711 11,120
Operating lease liabilities, current
1,152 1,172 1,184 1,148
Total current liabilities
11,054 15,664 14,891 13,431
Operating lease liabilities, non-current
1,263 1,537 1,805 2,115
Total liabilities
12,317 17,201 16,696 15,546
Common stock, 0.001 par value 500,000,000 shares authorized as of march 31, 2026 and december 31, 2025 38,745,032 and 31,648,856 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
38 31 31 31
Additional paid-in capital
389,396 387,255 384,356 380,562
Accumulated other comprehensive income
4 111 112 106
Accumulated deficit
-293,923 -274,881 -255,896 -237,662
Total stockholders' equity
95,515 112,516 128,603 143,037
Total liabilities and stockholders' equity
107,832 129,717 145,299 158,583
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$63,673K Cash and cashequivalents$34,064K Prepaid expenses andother current assets$1,483K Total property andequipment$8,354K Total current assets$99,220K Property and equipment,net$4,653K Operating leaseright-of-use assets$2,255K Other assets$1,510K Restricted cash$194K Less accumulateddepreciation$3,701K Total assets$107,832K Total liabilities andstockholders' equity$107,832K Total stockholders'equity$95,515K Total liabilities$12,317K Accumulated deficit-$293,923K Additional paid-in capital$389,396K Total currentliabilities$11,054K Operating leaseliabilities, non-current$1,263K Common stock, 0.001 parvalue 500,000,000...$38K Accumulated othercomprehensive income$4K Accrued expenses andother current...$8,740K Accounts payable$1,162K Operating leaseliabilities, current$1,152K

Acrivon Therapeutics, Inc. (ACRV)

Acrivon Therapeutics, Inc. (ACRV)